Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)
Veterinary and Comparative Oncology · 2024-09 · 22 (3) · 429-436
DOI: 10.1111/vco.12991 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 18.06.2024. Verfasst von Tracy L Gieger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Dog Diseases, Pituitary Neoplasms, Radiosurgery, Dose Fractionation, Radiation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Although canine pituitary masses (PM) are increasingly treated with stereotactic radiotherapy (SRT), historical literature supports superior outcomes with conventional full‐course fractionated radiation therapy (FRT). A multi‐institutional retrospective study was performed, including dogs with PM treated from 2016 to 2022 with SRT (total dose 30 or 35 Gy in 5 daily fractions) or FRT (total dose 50–54 Gy in 19–20 daily fractions). The influence of potential prognostic/predictive factors was assessed, including pituitary: brain height, pituitary: brain volume, sex, age and endocrine status (functional [F] vs. nonfunctional [NF] PM). Forty‐four dogs with PM were included (26 F, 14 NF, 4 unknown). All patients completed protocols as scheduled (SRT = 27, FRT = 17) and two dogs had suspected Grade 1 acute neurotoxicity. During the first 6 months after RT, 5/27 (19%) dogs treated with SRT (4 F, 1 NF) and 3/17 (18%) dogs treated with FRT (all F) died or were euthanised because of progressive neurologic signs. The overall median survival time was 608 days (95% CI, 375–840 days). Young age at the time of treatment was significant for survival ( p = 0.0288); the overall median survival time was 753 days for dogs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
- Department of Small Animal Clinical Sciences, Michigan State University, East Lansing, Michigan, USA.
- Angell Memorial Animal Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Tracy L Gieger, Hiroto Yoshikawa, Michael W Nolan
Zitieren
APA
Gieger, T. L., Magestro, L., Walz, J., Yoshikawa, H., & Nolan, M. W. (2024). Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022). Veterinary and Comparative Oncology, 22(3), 429-436. https://doi.org/10.1111/vco.12991
Vancouver
Gieger TL, Magestro L, Walz J, Yoshikawa H, Nolan MW. Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022). Veterinary and Comparative Oncology. 2024;22(3):429-436. doi:10.1111/vco.12991
BibTeX
@article{Gieger2024,
author = {Gieger, Tracy L and Magestro, Leanne and Walz, Jillian and Yoshikawa, Hiroto and Nolan, Michael W},
title = {Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)},
journal = {Veterinary and Comparative Oncology},
year = {2024},
volume = {22},
number = {3},
pages = {429--436},
doi = {10.1111/vco.12991}
}
EUVIMED